Free Trial

Sartorius Aktiengesellschaft (OTCMKTS:SARTF) Stock Price Down 3.9% - What's Next?

Sartorius Aktiengesellschaft logo with Medical background

Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report)'s stock price dropped 3.9% during mid-day trading on Tuesday . The stock traded as low as $200.05 and last traded at $200.05. Approximately 70 shares changed hands during trading, a decline of 29% from the average daily volume of 99 shares. The stock had previously closed at $208.18.

Analyst Upgrades and Downgrades

Separately, DZ Bank upgraded Sartorius Aktiengesellschaft from a "strong sell" rating to a "hold" rating in a report on Thursday, April 17th.

Read Our Latest Research Report on Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft Stock Performance

The company has a market cap of $6.85 billion, a price-to-earnings ratio of 151.55 and a beta of 1.12. The company has a quick ratio of 1.13, a current ratio of 2.02 and a debt-to-equity ratio of 1.17. The business's fifty day simple moving average is $193.33 and its two-hundred day simple moving average is $198.26.

Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) last posted its earnings results on Wednesday, April 16th. The company reported $1.28 EPS for the quarter, meeting analysts' consensus estimates of $1.28. Sartorius Aktiengesellschaft had a net margin of 2.48% and a return on equity of 7.33%. The firm had revenue of $959.23 million for the quarter, compared to the consensus estimate of $867.08 million.

About Sartorius Aktiengesellschaft

(Get Free Report)

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.

Featured Stories

Should You Invest $1,000 in Sartorius Aktiengesellschaft Right Now?

Before you consider Sartorius Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sartorius Aktiengesellschaft wasn't on the list.

While Sartorius Aktiengesellschaft currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines